Cota Raises $40M Series C

February 21, 2018

Cota will leverage funding to scale its solutions across health care providers, payers and life sciences companies. The funding will also advance its proprietary Cota Nodal Address(TM) (CNA) system, a powerful and unique precision disease classification system built on its comprehensive real-world data set. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings. (This story was also featured in MedCity News and Venture Capital News.)

Read full article on citybizlist.com.